Senaparib free base
Senaparib is a novel, highly effective, selective oral PARP1/2 inhibitor with strong anti-tumor activity in preclinical studies. Senaparib demonstrated encouraging clinical benefit and good tolerability in patients with advanced solid tumors.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0072 |
| Pricing | 5.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, inquire |